Hepatitis C virus persisting after clinically apparent sustained virological response to antiviral therapy retains infectivity in vitro

Hepatology

Volumn 49, Issue 5, 2009, Pages 1431-1441

  MacParland, Sonya A ^a   Pham, Tram N Q ^a   Guy, Clifford S ^a   Michalak, Tomasz I ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; NONSTRUCTURAL PROTEIN 5A; PEGINTERFERON; RIBAVIRIN; VIRUS RNA; CD81 ANTIGEN; GLYCOPROTEIN E2, HEPATITIS C VIRUS; LEUKOCYTE ANTIGEN; MONOCLONAL ANTIBODY; NS 5 PROTEIN, HEPATITIS C VIRUS; NS-5 PROTEIN, HEPATITIS C VIRUS; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

5' UNTRANSLATED REGION; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; GENE DELETION; GENE EXPRESSION; GENE SEQUENCE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOELECTRON MICROSCOPY; IN VITRO STUDY; LYMPHOID CELL; MALE; NUCLEIC ACID HYBRIDIZATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SERODIAGNOSIS; SUPERNATANT; T LYMPHOCYTE; TREATMENT DURATION; VIRION; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS MORPHOLOGY; VIRUS PARTICLE; VIRUS REPLICATION; BLOOD; CELL CULTURE; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PATHOGENICITY; ULTRASTRUCTURE; VIROLOGY;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIVIRAL AGENTS; CELLS, CULTURED; FEMALE; GENOME, VIRAL; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; RIBAVIRIN; RNA, VIRAL; T-LYMPHOCYTES; VIRAL ENVELOPE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 66149131434     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22802     Document Type: Article

References (22)

1. Katayama K, Kumagai J, Komiya Y, Mizui M, Yugi H, Kishimoto S, et al. Titration of hepatitis C virus in chimpanzees for determining the copy number required for transmission. Intervirology 2004;47:57-64.
2. Pham TN, MacParland SA, Mulrooney PM, Cooksley H, Naoumov NV, Michalak TI. Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J Virol 2004;78:5867-5874.
3. Radkowski M, Gallegos-Orozco JF, Jablonska J, Colby TV, Walewska-Zielecka B, Kubicka J, et al. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. HEPATOLOGY 2005;41:106-114.
4. Castillo I, Rodriguez-Inigo E, Lopez-Alcorocho JM, Pardo M, Bartolome J, Carreno V. Hepatitis C virus replicates in the liver of patients who have a sustained response to antiviral treatment. Clin Infect Dis 2006;43:1277-1283.
5. Laskus T, Operskalski EA, Radkowski M, Wilkinson J, Mack WJ, deGiacomo M, et al. Negative-strand hepatitis C virus (HCV) RNA in peripheral blood mononuclear cells from anti-HCV-positive/HIV-infected women. J Infect Dis 2007;195:124-133.
6. Pham TNQ, Mulrooney-Cousins PM, Mercer SE, MacParland SA, Inglot M, Zalewska M, et al. Antagonistic expression of hepatitis C virus and interferon alpha in lymphoid cells during persistent occult infection. J Viral Hepat 2007;14:537-548.
7. Pham TN, King D, MacParland SA, McGrath JS, Reddy SB, Bursey FR, et al. Hepatitis C virus replicates in the same immune cell subsets in chronic hepatitis C and occult infection. Gastroenterology 2008;134:812-82.
8. Pham TNQ, MacParland SA, Coffin CS, Lee SS, Bursey FR, Michalak TI. Mitogen-induced upregulation of hepatitis C virus expression in human lymphoid cells. J Gen Virol 2005;86:657-666.
9. MacParland SA, Pham TNQ, Gujar SA, Michalak TI. De novo infection and propagation of wild-type hepatitis C virus in human T lymphocytes in vitro. J Gen Virol 2006;87:3577-3586.
10. Pal S, Sullivan DG, Kim S, Lai KKY, Kae J, Cotler SJ, et al. Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications of HCV lymphotropism. Gastroenterology 2006;130:1107-1116.
11. Blackard JT, Kemmer N, Sherman KE. Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. HEPATOLOGY 2006;44:15-22.
12. Dahari H, Feliu A, Garcia-Retortillo M, Forns X, Neumann AU. Second hepatitis C replication compartment indicated by viral dynamics during liver transplantation. J Hepatol 2005;42:491-498.
13. Thomas RM, Brems JJ, Guzman-Hartman G, Yong S, Cavaliere P, Van Thiel DH. Infection with chronic hepatitis C virus and liver transplantation: a role for interferon therapy before transplantation. Liver Transpl 2003;9:905-915.
14. Forns X, Garcia-Retortillo M, Serrano T, Feliu A, Suarez F, de la Mata M, et al. Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation. J Hepatol 2003;39: 389-396.
15. Everson GT, Trotter J, Forman L, Kugelmas M, Halprin A, Fey B, et al. Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy. HEPATOLOGY 2005;42:255-262.
16. Zekri ARN, Mohamed WS, Samra MA, Sherif GM, El Shehaby AMR, El Sayed MH. Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation. Transplant Immunol 2004; 13:305-311.
17. Melon S, Galarraga MC, Villar M, Laures A, Boga JA, de Ona M, et al. Hepatitis C virus reactivation in anti-hepatitic C virus-positive renal transplant recipients. Transplant Proc 2005;37:2083-2085.
18. Michalak TI, Pham TN, Mulrooney-Cousins PM. Molecular diagnosis of occult HCV and HBV infections. Fut Virol 2007;2:451-465.
19. Hijikata M, Shimizu YK, Kato H, Iwamoto A, Shih JW, Alter HJ, et al. Equilibrium centrifugation studies of hepatitis C virus: Evidence for circulating immune-complexes. J Virol 1993;67:1953-1958.
20. Kanto T, Hayashi N, Takehara T, Hagiwara H, Mita E, Naito M, et al. Buoyant density of hepatitis C virus recovered from infected hosts; two different features in sucrose equilibrium density-gradient centrifugation related to degree of liver inflammation. HEPATOLOGY 1994;19:296-302.
21. Diaz O, Delers F, Maynard M, Demignot S, Zoulim F, Chambaz J, et al. Preferential association of hepatitis C virus with apolipo-protein B48-containing lipoproteins. J Gen Virol 2006;87:2983-2991.
22. Feinstone SM, Alter HJ, Dienes HP, Shimizu Y, Popper H, Blackmore D, et al. Non-A, non-B hepatitis in chimpanzees and marmosets. J Infect Dis 1981;144:588-598.